Psyence Biomedical Ltd (PBM)
1.20
+0.08
(+7.14%)
USD |
NASDAQ |
Mar 27, 16:00
1.18
-0.02
(-1.67%)
Pre-Market: 08:51
Psyence Biomedical Enterprise Value: 16.20M for March 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 27, 2024 | 16.20M |
March 26, 2024 | 15.13M |
March 25, 2024 | 15.27M |
March 22, 2024 | 14.86M |
March 21, 2024 | 15.67M |
March 20, 2024 | 15.94M |
March 19, 2024 | 17.41M |
March 18, 2024 | 16.87M |
March 15, 2024 | 17.41M |
March 14, 2024 | 21.43M |
March 13, 2024 | 14.06M |
March 12, 2024 | 16.61M |
March 11, 2024 | 23.84M |
March 08, 2024 | 28.39M |
March 07, 2024 | 17.14M |
March 06, 2024 | 13.79M |
March 05, 2024 | 11.65M |
March 04, 2024 | 8.444M |
March 01, 2024 | 7.794M |
February 29, 2024 | 7.500M |
February 28, 2024 | 7.767M |
February 27, 2024 | 8.034M |
Date | Value |
---|---|
February 26, 2024 | 8.075M |
February 23, 2024 | 7.425M |
February 22, 2024 | 7.410M |
February 21, 2024 | 7.808M |
February 20, 2024 | 8.975M |
February 16, 2024 | 9.096M |
February 15, 2024 | 9.044M |
February 14, 2024 | 9.307M |
February 13, 2024 | 10.04M |
February 12, 2024 | 11.28M |
February 09, 2024 | 11.01M |
February 08, 2024 | 12.82M |
February 07, 2024 | 15.80M |
February 06, 2024 | 20.22M |
February 05, 2024 | 19.19M |
February 02, 2024 | 19.55M |
February 01, 2024 | 23.17M |
January 31, 2024 | 23.97M |
January 30, 2024 | 24.91M |
January 29, 2024 | 26.92M |
January 26, 2024 | 31.60M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
7.410M
Minimum
Feb 22 2024
31.60M
Maximum
Jan 26 2024
15.09M
Average
15.13M
Median
Mar 26 2024
Enterprise Value Benchmarks
Lucy Scientific Discovery Inc | 3.272M |
Lexaria Bioscience Corp | 36.32M |
Acasti Pharma Inc | 6.844M |
Aurinia Pharmaceuticals Inc | 372.60M |
Edesa Biotech Inc | 9.847M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.3181M |
Total Expenses (Quarterly) | 0.1761M |
EPS Diluted (Quarterly) | -0.025 |